Pasar al contenido principal

FUNCIONALIDAD MITOCONDRIAL Y ESTRES OXIDATIVO EN UN ESTUDIO DE PRUEBA DE CONCEPTO FASE II PARA EVALUAR LA EFICACIA Y SEGURIDAD DE LOS CORTICOIDES EN EL TRATAMIENTO DE LA DILI

PID2022-140169OB-C22

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2022
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 7
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation

  • Baulies, Anna
  • Torres, Sandra
  • Fucho, Raquel|||0000-0002-1774-9099
  • Núñez Pereira, Susana
  • Torres, Ferran|||0000-0002-7355-7913
  • Ferrer-Fàbrega, Joana
  • Díaz, Alba|||0000-0002-0456-7085
  • Rico, Naira
  • García-Valdecasas, Juan Carlos
  • Fuster, Josep
  • Adàlia, Ramon|||0009-0004-9458-1922
  • Paredes, David
  • Rimola, Antoni
  • Fernández-Checa, José C.
  • García-Ruiz, Carmen
Hepatic steatosis presents a rising challenge in liver transplantation (LT), yet the precise underlying players remain incompletely understood. As steatosis reflects the accumulation of several types of lipids, including cholesterol, which has emerged as a key player in metabolic-dysfunction associated fatty liver disease, we aimed to characterize the content of lipids and the expression of cholesterol metabolic genes in liver biopsies before (pre-LT) and after LT (post-LT), with the ultimate goal of identifying factors that may impact graft loss and the overall outcomes of LT. Lipid content and cholesterol-related genes in pre- and post-LT graft biopsies, clinical outcome, and survival within the first year after LT were analyzed in 174 patients. Unlike free fatty acids (FFA) and triglycerides, total and free cholesterol (FC) levels are maintained in pre- and post-LT samples. Increased FC and FFA levels in pre-LT samples were associated with early allograft dysfunction (EAD). The increase in the expression of cholesterol regulatory genes SREBF2 and HMGCR in pre-LT samples was identified as a potential risk factor of death after LT, particularly with SREBF2, whose expression is associated with EAD and graft loss (GL). Collectively, these data link the expression of genes involved in the synthesis of cholesterol to LT-related mortality. These findings may translate to an increased application of marginal steatotic grafts in LT, thereby promoting a safe outcome.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Cholesterol's new tricks propel MASH-HCC: impact in immunotherapy

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Mitochondrial ROS, a trigger for mitochondrial dysfunction and inflammasome activation and a therapeutic target in liver diseases

  • Jaara, Hala Saeed
  • Torres, Sandra
Mitochondria are essential organelles responsible for intracellular energy production and play crucial roles in cellular metabolism, inflammation, and apoptosis. Reactive oxygen species (ROS) are primarily produced in the mitochondria and endoplasmic reticulum of hepatocytes due to the activity of cytochrome P450 enzymes. Under ideal conditions, cells have specific molecular mechanisms that manage oxidative stress levels, thus ensuring a balance between oxidants and antioxidants. The interplay between ROS-induced mitochondrial dysfunction and the activation of the NLRP3 (nucleotide-binding oligomerization domainlike receptor family, pyrin domain containing 3) inflammasome in the context of liver diseases has been extensively studied. However, the exact mechanisms by which mitochondria promote the activation of the NLRP3 inflammasome and contribute to the onset of liver disease remain unclear. This review aims to elucidate the recently discovered mitochondrial regulation of the NLRP3 inflammasome in liver disorders, including alcohol-related liver disease (ALD), metabolic-associated steatotic liver disease (MASLD), and hepatocellular carcinoma (HCC). Finally, it summarizes various natural and pharmaceutical agents that can mitigate liver damage by modulating the activation of the NLRP3 inflammasome through mitochondrial pathways. This work serves as an important resource for identifying new therapeutic approaches and provides further support for advancing the understanding of liver diseases, We acknowledge the support from the grants [PID2022-140169OB-C22] from Plan Nacional de I+D funded by the Agencia Estatal de Investigación (AEI) and from Beatriu de Pinós Post-doctoral grant [2021 BP00187]; as well as from the CIBER, the intramural project grant for junior researchers [CIBEREHD 2023] and the support from AGAUR of the Generalitat de Catalunya [SGR-2021-00491]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation

  • Baulies, Anna
  • Torres, Sandra
  • Fucho, Raquel
  • Nuñez, Susana
  • Torres, Ferrán
  • Ferrer, Joana
  • Díaz, Alba
  • Rico, Naira
  • García-Valdecasas, Juan Carlos
  • Fuster, Josep
  • Adalia, Ramón
  • Paredes, David
  • Rimola, Antoni
  • Fernández-Checa, José C.
  • García-Ruiz, Carmen
We acknowledge the support from the grants Fundación Mutua Madrileña; grants PID2022-142956OB-100, PID2022-140169OB-C22 and PID2023-148803OB-100 from Plan Nacional de I + D funded by the Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; as well as support from National Cancer Institute PO1 CA281819-01A1 from the NIH; AGAUR of the Generalitat de Catalunya SGR-2021-00491; ST holds a Ramón y Cajal fellowship (RYC2023-042649-I), and has received research support from the CIBEREHD intramural project 2023 (EHD25PI01). In addition, this project has received funding from the European Horizon's research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

L‑Cysteine-Glutathione Mixed Disulfide, a Novel Bioavailable Sulfhydryl-Modified Glutathione Precursor, Protects against Early Liver Injury Induced by Short-Term Hypercholesterolemia

  • Martínez-Gili, Laura
  • Fucho, Raquel
  • Caballero, Francisco
  • Nuñez, Susana
  • Jaara, Hala Saeed
  • Alarcón-Vila, Cristina
  • Rico, Naira
  • Nagasawa, Herbert T.
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
  • Torres, Sandra
Oxidative stress contributes to the damage of biological molecules and is linked to the development of multiple diseases, including liver disorders, such as metabolic dysfunction-associated steatotic liver disease (MASLD). In mammals, reduced glutathione (GSH) is a pivotal antioxidant that regulates cellular responses to redox imbalances caused by reactive oxygen and nitrogen species. The presence of reduced GSH within mitochondria is especially crucial for preserving the organelle’s routine performance by eliminating hydrogen peroxide generated under both physiological and pathological conditions. Cumulative evidence indicates that MASLD is associated with a diminished mitochondrial GSH (mGSH) pool, attributed to alterations in mitochondrial membrane fluidity due to cholesterol accumulation. Therefore, strategies aimed at boosting mGSH may offer therapeutic benefits against MASLD-associated liver injury. This study aims to investigate whether l-cysteine-glutathione disulfide (l-CySSG), a proposed GSH donor and precursor, can effectively restore total and mGSH in vitro and in vivo in mice fed cholesterol-enriched (HC) or methionine-choline-deficient (MCD) diets. Additionally, S-adenosylmethionine (SAM), a compound that serves as both a GSH precursor and a membrane fluidizer, along with N-acetylcysteine (NAC), a GSH precursor by providing cysteine, was used as the control molecules in the study. Our findings show that l-CySSG has great potential as a liver protector, especially due to its good oral bioavailability. Although it does not restore GSH levels in the mitochondria as efficiently as SAM does, l-CySSG can still offer protection against liver damage, possibly through mechanisms that are not yet fully understood. Overall, l-CySSG emerges as a promising alternative for treating conditions related to oxidative stress and mitochondrial dysfunction, paving the way for future research and therapeutic development., We are grateful for the support from grants PID2019- 111669RB-I00, PID2020-115055RB-I00, PID2022- 140169OB-C22 and PID2023-148803OB-100 from Plan Nacional de I+D funded by the Agencia Estatal de Investigacioń (AEI); Fondo Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; AGAUR of the Generalitat de Catalunya SGR-2021-00491; National Cancer Institute PO1 CA281819-01A1 from the NIH; 2024I076 from Government Delegation for the National Plan on Drugs (Ministry of Health). In addition, this project has received funding from the European Horizon’s research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679. ST holds a Ramoń y Cajal fellowship (RYC2023-042649-I), and has received research support from the CIBEREHD intramural project 2023 (EHD25PI01)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Contribución de congreso (ConferenceOutput)

Cholesterol metabolic reprogramming in alcohol associated liver disease

  • Barrios, Mónica
  • Torres, Sandra
  • Fàbrega, Laura
  • Nuñez, Susana
  • Fucho, Raquel
  • Solsona-Vilarrasa, Estel
  • Rico, Naira
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
Trabajo presentado en el ASBMB Annual Meeting (2026), celebrado en Washington, D.C.(Estado Unidos), del 7 al 10 de marzo de 2026, We acknowledge the support from the grants PID2023-148803OB-I00, PID2022-142956OB-I00 and PID2022-140169OB-C22 from Plan Nacional de I+D funded by the Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; as well as “Plan Nacional sobre Drogas” 2024 from the Ministry of Health, and support from AGAUR of the Generalitat de Catalunya SGR-2021-00491; CIBEREHD intramural project grant for junior researchers 2023; European Cooperation in Science & Technology (COST) ACTION CA17112 Prospective European Drug- Induced Liver Injury Network. National Cancer Institute PO1 CA281819-01A1 from the NIH; Beatriu de Pinós Post-doctoral grant (2021 BP00187); and from the European Horizon's research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679. ST holds a Ramón y Cajal fellowship (RYC2023-042649-I)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Prenols and prenoic acids in metabolism, disease, and aging

  • Verdaguer, Ignasi Bofill
  • Hernández, Agustín
  • Torres, Sandra
  • Rodríguez-Peiris, Maria
  • Arenas, Fabian
  • Martinez, Damelia Echevarria
  • López, Monica Barrios
  • Crispim, Marcell
  • Tabata, Yuki
  • García-Ruiz, Carmen
  • Fernández-Checa, José C.
Acyclic terpene derivatives are well-known as components of plant essential oils and insect hormones, yet their active biosynthesis also occurs in mammals. The terpenic alcohols-or prenols-geranylgeraniol (GGOH) and farnesol (FOH), together with their prenoic acids and derivatives, were identified in mammalian cells over 60 years ago but remain largely overlooked. These metabolites display diverse biological functions: they induce autophagy, inhibit tumor growth and inflammation, suppress cholesterol synthesis, enhance insulin sensitivity and cognition, regulate sexual characteristics, and promote healthy aging. In mammals, prenols arise from an age-dependent, bidirectional pathway that interconverts polyprenyl diphosphates, prenols, and prenoic acids. They can be oxidized into aldehydes and carboxylic acids or reconverted into diphosphate forms for use in protein prenylation and in the biosynthesis of ubiquinone, cholesterol, and dolichol. Although enzymes catalyzing polyprenyl diphosphate dephosphorylation and oxidation steps have been partly characterized, the kinases mediating their reverse phosphorylation remain unidentified. This review summarizes current advances in the understanding of prenol metabolism in mammals, emphasizing its role in metabolic regulation, disease prevention, and longevity. By integrating biochemical and physiological evidence, we highlight the emerging view that these small terpenes constitute a fundamental yet underexplored layer of metabolic control. Greater attention to this pathway may reveal novel strategies for maintaining metabolic health and mitigating age-related disorders., I. B. V. is fellow from the Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP); I. B. V. FAPESP process number: 2022/09526-4. M. C. was supported by a Beatriu de Pinós fellowship from AGAUR (Government of Catalonia). This work received support from the grants PID2022-142956OB-100, PID2022-140169OB-C22, and PID2023-148803OB-100 from Plan Nacional de I + D funded by the Agencia Estatal de Investigación (AEI) and the Fondo Europeo de Desarrollo Regional (FEDER) and from the CIBEREHD; as well as support from National Cancer Institute PO1 CA281819-01A1 from the NIH, and from the European Horizon's research and innovation program HORIZON-HLTH-2022-STAYHLTH-02 under agreement No 101095679. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health., Peer reviewed